Clinical Trial Update: Observational Study on the Weight Effect of Insulin Detemir (Levemir®) in Type 2 Diabetics

View source ↗

Summary

This document reports the completion of an observational study evaluating the weight effects of insulin detemir (Levemir) in people with Type 2 diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Levemir (insulin detemir)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 2 | Status: COMPLETED